Cargando…
A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany
In Germany, the recently approved 20-valent pneumococcal conjugate vaccine had a substantially higher coverage against pneumonia in adults than the 13-valent vaccine, while the coverage gap compared to the 23-valent polysaccharide vaccine was small https://bit.ly/3q4skov
Autores principales: | Bahrs, Christina, Kesselmeier, Miriam, Kolditz, Martin, Ewig, Santiago, Rohde, Gernot, Barten-Neiner, Grit, Rupp, Jan, Witzenrath, Martin, Welte, Tobias, Pletz, Mathias W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812468/ https://www.ncbi.nlm.nih.gov/pubmed/34824055 http://dx.doi.org/10.1183/13993003.02432-2021 |
Ejemplares similares
-
Early post-discharge mortality in CAP: frequency, risk factors and a prediction tool
por: Glöckner, Verena, et al.
Publicado: (2022) -
Unmet needs in pneumonia research: a comprehensive approach by the CAPNETZ study group
por: Pletz, Mathias W., et al.
Publicado: (2022) -
Serotype transmission dynamics and reduced incidence of invasive pneumococcal disease caused by different serotypes after implementation of non-pharmaceutical interventions during COVID-19 pandemic
por: Janapatla, Rajendra Prasad, et al.
Publicado: (2021) -
Advances in the prevention, management, and treatment of community-acquired pneumonia
por: Pletz, Mathias W., et al.
Publicado: (2016) -
Collapse induration of alveoli is an ultrastructural finding in a COVID-19 patient
por: Ochs, Matthias, et al.
Publicado: (2021)